Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Graft-versus-host Disease (GVHD): full-pipeline trial registry
2 of 4 indexed Graft-versus-host Disease (GVHD) trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Graft-versus-host Disease (GVHD): 4 US clinical trials tracked, 2 recruiting.
Graft-versus-host Disease (GVHD) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Nebraska, running 2 of these trials.
Enrollment posture brief
Registry condition graft-versus-host-disease-gvhd
OPEN 2 | RECR 50% | LATE 2 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Graft-versus-host Disease (GVHD) lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Graft-versus-host Disease (GVHD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Graft-versus-host Disease (GVHD) is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Incyte Corporation
NCT06615050
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
University of Nebraska
NCT06799195
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Incyte Corporation
NCT03139604
Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
University of Nebraska
NCT03616184
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Graft-versus-host Disease (GVHD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Graft-versus-host Disease (GVHD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Graft-versus-host Disease (GVHD) page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Graft-versus-host Disease (GVHD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Nebraska sponsors the most Graft-versus-host Disease (GVHD) trials on record, review their full trial history before evaluating a specific study. See University of Nebraska's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Graft-versus-host Disease (GVHD) condition card totals 4 registered trials; most-linked intervention Mycophenolate Mofetil (MMF); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.